Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
about
Sterol regulatory element-binding protein-1c orchestrates metabolic remodeling of white adipose tissue by caloric restrictionHsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signalingDe Novo Lipogenesis Products and Endogenous Lipokines.Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action.The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesisEpigenetic regulation of the ELOVL6 gene is associated with a major QTL effect on fatty acid composition in pigs.2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucoseGermline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.Lack of mitochondria-generated acetyl-CoA by pyruvate dehydrogenase complex downregulates gene expression in the hepatic de novo lipogenic pathway.Lack of association between SREBF-1c gene polymorphisms and risk of non-alcoholic fatty liver disease in a Chinese Han population.Identification of combined genetic determinants of liver stiffness within the SREBP1c-PNPLA3 pathway.Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic ratsMicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis.Developmental and extrahepatic physiological functions of SREBP pathway genes in mice.Allyl isothiocyanate suppresses the proteolytic activation of sterol regulatory element-binding proteins and de novo fatty acid and cholesterol synthesis.Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation.Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2.Ghrelin function in human obesity and type 2 diabetes: a concise review.MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells.Can LDL cholesterol be too low? Possible risks of extremely low levels.Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer.Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver.Zinc mediates the SREBP-SCD axis to regulate lipid metabolism in Caenorhabditis elegans.Inactivation of SREBP-1a Phosphorylation Prevents Fatty Liver Disease in Mice: Identification of Related Signaling Pathways by Gene Expression Profiles in Liver and Proteomes of Peroxisomes.Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease.Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitisNew mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling
P2860
Q33638913-0517D368-387A-4624-8A8A-993674E10150Q33945101-EEFC0D66-0BAB-499E-8017-0949C8DE8DA0Q33948324-5589D7E0-EC69-4C97-ADDF-23518300D511Q34170848-49376458-011D-4423-BB90-8EB8DD9784AFQ34530470-36CCD5BE-94B5-4626-921D-80BA4E57C4AAQ34603569-B9C4D4A2-148A-4516-8596-B1835FB46F1EQ34642326-1BD67604-AC01-47F5-A7CA-0DF4FC016E6CQ35211627-37E17481-C6AA-4D7E-9FFF-608F1934AA42Q35289357-CF692F2C-4C73-44C1-A21C-869852CC3874Q36527942-C1913E14-41B9-46CC-AEAF-1408D7A84CD0Q36800168-594EE4F7-C611-439B-BD64-B66E4C045602Q36891677-B956C4C8-7983-4D15-B5DB-D100CFBFB354Q37088326-3951C29B-A705-489E-B5A3-B36FA4AC9AE4Q37139402-3850CB94-79DE-419F-9E5E-153288B02B0CQ37215867-078E73A7-5F4D-4EE0-A32D-2E4E0F3EAC0AQ37291432-CCAA4AA3-64BA-40B1-8D67-EEEFA7248147Q37294679-1847D367-81D8-4BEF-A960-2103E8DB50A5Q37394060-0BBC303F-F89B-40A5-8E12-D83BF28F815AQ37583530-28521E9E-5008-4560-A09C-4B017DE62E71Q38653024-497FD7FF-E38D-4E5C-809E-35632D55484FQ38798594-BABB7D11-4960-4F0D-B926-89BACEC40436Q38856934-A7645C2B-5BFD-4B79-9CD4-B109C74A5584Q38944183-BFD6981F-00FE-423E-871B-94731182A12AQ39023729-7F9581D6-9A8B-4793-BC8C-F462964C3183Q39038069-75251FA9-1D15-4D95-9947-740606D908D9Q39148101-AA03FB24-A1BF-463B-B210-DCACC828643BQ39179689-58F34C36-96DF-415E-8251-F93EDC096865Q41839667-166662B3-3553-487C-8BB8-B417FF745AC0Q46368143-0683F622-095E-4C2A-BA67-AE706CD9C3B0Q50889958-50169B16-B85F-445B-966D-31D19A9464F4Q52690273-BEE41982-83F8-49BD-8CD5-8A9B79957E35Q54117341-5E04F495-AEE0-42B9-8531-6E8EAB268821Q57114745-12EF835A-8B46-42A5-B995-C1E00CFCC538Q58145237-CE7B9388-9A64-414D-8A42-D56261CA1620
P2860
Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Liver-specific expression of t ...... d increased visceral fat mass.
@ast
Liver-specific expression of t ...... d increased visceral fat mass.
@en
Liver-specific expression of t ...... d increased visceral fat mass.
@nl
type
label
Liver-specific expression of t ...... d increased visceral fat mass.
@ast
Liver-specific expression of t ...... d increased visceral fat mass.
@en
Liver-specific expression of t ...... d increased visceral fat mass.
@nl
prefLabel
Liver-specific expression of t ...... d increased visceral fat mass.
@ast
Liver-specific expression of t ...... d increased visceral fat mass.
@en
Liver-specific expression of t ...... d increased visceral fat mass.
@nl
P2093
P2860
P1433
P1476
Liver-specific expression of t ...... d increased visceral fat mass.
@en
P2093
Birgit Knebel
Cornelia Köllmer
Dirk Muller-Wieland
Jutta Haas
Sonja Hartwig
Sylvia Jacob
Ulrike Nitzgen
P2860
P304
P356
10.1371/JOURNAL.PONE.0031812
P407
P50
P577
2012-02-21T00:00:00Z